Anzeige
Mehr »
Lynx Broker
Login
Dienstag, 22.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A141DB ISIN: CA00430K4028 Ticker-Symbol: A1PA 
Frankfurt
21.10.19
13:09 Uhr
1,870 Euro
-0,020
-1,06 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ACASTI PHARMA INC Chart 1 Jahr
5-Tage-Chart
ACASTI PHARMA INC 5-Tage-Chart

Aktuelle News zur ACASTI Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.10.Acasti Pharma And Amarin In Severe Hypertriglyceridemia25
03.10.Acasti Pharma (ACST) Investor Presentation - Slideshow1
Börsennews zur ACASTI Aktie und weiteren Hot Stocks erhalten
30.09.NA Proactive news snapshot: Acasti Pharma, EnWave, NetCents Technology, GlobeX Data UPDATE …24
30.09.Acasti Pharma Inc (2): Acasti's Trilogy reaches 100% patient randomization1
30.09.Acasti Pharma on pace to release Phase 3 trial results of lead drug candidate CaPre in December1
30.09.Acasti Pharma, Inc.: Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report ...-
30.09.Acasti Pharma Inc. - 6-K, Report of foreign issuer-
18.09.Acasti Pharma (ACST) Investor Presentation - Slideshow3
09.09.Canada to support Acasti's CaPre R&D with $750K grant-
09.09.Acasti Pharma Inc (2): Acasti Pharma receives $750,000 Cdn gov't funding2
09.09.Acasti Pharma awarded $750K by Canadian government to help develop flagship drug candidate CaPre-
09.09.Acasti Pharma receives $750,000 funding to develop CaPre1
04.09.Acasti Pharma Inc. - 6-K, Report of foreign issuer-
28.08.Acasti Pharma Inc (2): Acasti Pharma shareholders elect four directors at AGM3
28.08.Acasti Pharma Inc. - 6-K, Report of foreign issuer-
28.08.Acasti Pharma, Inc.: Acasti Pharma Announces the Election of Its Directors, Amendments to Its Stock Option and ...-
14.08.NA Proactive news snapshot: Duos Technologies, Capstone Turbine, Acasti Pharma, Biome Grow …11
14.08.Acasti Pharma Inc (2): Acasti spends $7.4-million on R&D in fiscal Q1 20201
14.08.Acasti Pharma says on track to release new CaPre trial results by end of 2019 after fruitful 1Q2
14.08.Acasti Pharma, Inc.: Acasti Pharma Provides Business Update for the First Quarter of Fiscal 20201
Seite:  Weiter >>
70 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1